《生物安全法案》“搭便车”NDAA失败,国内CXO板块迎反弹

每日经济新闻
09 Dec 2024

每经记者:许立波    每经编辑:杨夏当地时间12月7日,美国国会参众两院军事委员会公布了2025财年国防授权法案(以下简称“NDAA”)最终协议文本,该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示,《生物安全法案》未被列入其中,意味着《生物安全法案》通过“夹带”进NDAA进而实现立法的路径失败。受该利好消息刺激,12月9日开盘,CXO(医药外包)板块有所反弹,药明康德(603259...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10